2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

{"article_title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.","author":"","journal_title":"Atherosclerosis","issn":"1879-1484","isbn":"","publication_date":"2019-11-01","volume":"290","issue":"","first_page":"140","page_count":"","accession_number":"31591002","doi":"10.1016\/j.atherosclerosis.2019.08.014","publisher":"Elsevier","doctype":"Journal Article","subjects":"Cardiovascular Diseases prevention & control; Dyslipidemias drug therapy; Hypolipidemic Agents therapeutic use; Lipids blood; Adult; Aged; Biomarkers blood; Cardiovascular Diseases diagnosis; Cardiovascular Diseases epidemiology; Consensus; Drug Therapy, Combination; Dyslipidemias blood; Dyslipidemias diagnosis; Dyslipidemias epidemiology; Female; Humans; Hypolipidemic Agents adverse effects; Male; Middle Aged; Risk Assessment; Risk Factors; Risk Reduction Behavior; Treatment Outcome","interest_area":["Cardiology"," Internal Medicine"],"abstract":"","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=31591002","isPdfLink":false,"isSAML":false,"an":"31591002","number_other":"","type_pub":"","issn_electronic":"1879-1484","languages":"English","language":"eng","date_entry":"Date Created: 20191009 Date Completed: 20200803 Latest Revision: 20200803","date_update":"20240104","titleSource":"Atherosclerosis [Atherosclerosis] 2019 Nov; Vol. 290, pp. 140-205. Date of Electronic Publication: 2019 Aug 31.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2019-11-01","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=31591002&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Authors\/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies"}